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E-mail address: mirande@lebs.cnrs-gif.frSeveral lines of evidence led to the conclusion that mammalian ribosomal protein synthesis is a
highly organized biological process in vivo. A wealth of data support the concept according to which
tRNA aminoacylation, formation of the ternary complex on EF1A and delivery of aminoacyl-tRNA to
the ribosome is a processive mechanism where tRNA is vectorially transferred from one component
to another. Polypeptide extensions, referred to as tRBDs (tRNA binding domains), are appended to
mammalian and yeast aminoacyl-tRNA synthetases. The involvement of these domains in the cap-
ture of deacylated tRNA and in the sequestration of aminoacylated tRNA, suggests that cycling of
tRNA in translation is mediated by the processivity of the consecutive steps. The possible origin of
the tRBDs is discussed.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Translation of genetic information into proteins involves a def-
inite set of nucleic acids and proteins. A cell free translation system
has been reconstituted with 46 tRNA species and 32 protein com-
ponents isolated from Escherichia coli (initiation, elongation and re-
lease factors, aminoacyl-tRNA synthetases, ribosome and
formylase) [1]. An essentially similar array of molecules is required
for ribosomal protein synthesis in eubacteria, archaea and eukary-
otes. The substrates of the protein-making machine, the ribosome,
are aminoacylated tRNAs that should be delivered in the form of a
ternary complex with elongation factor EF1A and GTP. Accordingly,
the EF1AGTPaa-tRNA should be non-limiting and represents the
major form of EF1A and tRNA in growing cells. After transfer of
the amino acid to the growing polypeptide chain on the ribosome,
deacylated tRNA replenishes the pool of EF1AGTPaa-tRNA follow-
ing aminoacylation by a family of 20 enzymes, one per amino acid,
the aminoacyl-tRNA synthetases. Several lines of evidence suggest
that during the elongation step of translation in the cytoplasm of
eukaryote cells tRNAs ﬂow in a closed circuit referred to as the
tRNA cycle (Fig. 1).
2. tRNA cycling
The concept of tRNA cycling in translation was proposed by
Smith in 1975 [2] and further reﬁned by Deutscher and co-workers
[3–6]. Using a permeabilized Chinese hamster ovary cell system,chemical Societies. Published by Ethey observed that exogenously added aminoacyl-tRNAs are poor
substrates for protein synthesis [3], that endogenous aminoacyl-
tRNAs are sequestered within the cell [4] and that there is no leak-
age of tRNA in the cellular ﬂuid after dissociating from the ribo-
somal E-site [6]. They concluded that tRNA is never freely
diffusing in the cytoplasm of mammalian cells, and should be al-
ways associated with components of the translation machinery.
It was shown that cytoplasmic conﬁnement of tRNA requires inter-
action with components of the translation apparatus in yeast [7],
but that retrograde accumulation of tRNAs in the nucleus of Sac-
charomyces cerevisiae [8] or of rat hepatoma cells [9] is observed
in response to amino acid deprivation. Thus, when the ﬂow of
the translation circuit is closed, tRNA is no more sequestered in
the cytoplasm. How a tRNA is vectorially transferred from one
component to the other at each step of the translational process,
and is sequestered in the cytosol, is not entirely understood. Recent
functional and structural data on mammalian aminoacyl-tRNA
synthetases provided some clues on how this family of enzymes
has evolved to ensure efﬁcient capture and sequestration of tRNA
at the aminoacylation step of the tRNA cycle in translation.
3. General RNA binding domains
As a general rule, eukaryotic aminoacyl-tRNA synthetases have
polypeptide chain extensions appended to the N- or C-terminal
extremity of their prokaryotic-like catalytic domains [10]. The ap-
pended domains of yeast aspartyl- [11], glutaminyl- [12] or valyl-
[13] tRNA synthetases are tRNA-binding domains (tRBD) that act in
cis of the catalytic domains to improve tRNA binding. Additional
tRBD can also be provided in trans, as in the case of the Arc1plsevier B.V. All rights reserved.
Fig. 1. The translation cycle. Along translation, tRNA is aminoacylated with a
cognate amino acid (aa) by an aminoacyl-tRNA synthetase (aaRS) to form an
aminoacyl-tRNA (aa  tRNA) which is delivered to the ribosome as a ternary
complex with elongation factor EF1A (EF1A:GTP:aa  tRNA). After transfer of the
amino acid to the growing polypeptide chain in response to codon recognition on
the ribosome, tRNA is released and enters a new translation cycle.
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thetases in yeast [14], and of the Pex21p protein that associates
with yeast seryl-tRNA synthetase [15].
Because yeast generally contains two distinct sets of aminoacyl-
tRNA synthetases, a eukaryotic cytosolic and a prokaryotic mito-
chondrial enzyme, it was interesting to analyze the requirement
for an additional tRBD in the two compartments. In the case of va-
lyl-tRNA synthetase, the yeast VAS1 gene encodes the two forms
through alternative initiation of translation [16]. Whereas valyl-
tRNA synthetase from E. coli complements the yeast cytoplasmic
enzyme only when a tRBD is appended in cis of its catalytic do-
main, complementation of the yeast mitochondrial enzyme does
not require an additional tRBD [13]. Similarly, the yeast cytosolic
glutamyl-tRNA synthetase is also the source of the mitochondrial,
non-discriminating enzyme when Arc1p is depleted [17]. Thus, the
functioning of glutamyl-tRNA synthetase in mitochondria does not
require its association with a tRBD. These results exemplify the
major role played by the appended tRBD in the context of transla-
tion in a eukaryotic environment, the cytosol, and show that theseFig. 2. RNA-binding appendices conferring processivity on methionyl-tRNA synthetase. (a
binding domain (ABD), is known in Aquifex aeolicus (Aa). In Saccharomyces cerevisiae (Sc) a
mediates association with Arc1p, a factor containing a tRNA-binding domain (tRBD). In th
the protein. In Homo sapiens (Hs), methionyl-tRNA synthetase contains a N-terminal PB
MARS, and a speciﬁc C-terminal tRBD. (b) The crystal structure of methionyl-tRNA synth
(c) The solution structure of human tRBD [24]. The side-chains of the amino acid residues
homologous to the tRBD of Arc1p and of the plant synthetase.domains are dispensable in the context of translation in a prokary-
otic environment, the mitochondria.
Many human cytosolic aminoacyl-tRNA synthetases also pos-
sess additional tRBD appended either in cis or in trans of their cat-
alytic domains. Methionyl-tRNA synthetase, which has been
extensively studied in a large variety of organisms, from bacteria
to mammals, revealed different scenario adopted along evolution
to link a tRBD to the catalytic domain (Fig. 2a). The minimum en-
zyme is found in some bacteria, such as Aquifex aeolicus, or in mito-
chondria. The crystal structure of the minimal enzyme has been
determined as a complex with tRNAMet (Fig. 2b) [18]. In several
bacteria, an OB-fold based dimerization domain is appended at
the C-terminus and improves tRNA binding [19]. In plants, such
as the rice Oryza sativa [20], an additional pseudo dimerization do-
main (Fig. 2d) is appended to this dimerization domain [21] and
leads to a monomeric enzyme which displays potent tRNA-binding
capacities (Kd of 0.08 lM for the native enzyme and of >2 lM for
the deleted enzyme) [20]. This tRBD associated in cis to plant
methionyl-tRNA synthetase is similar to the tRBD of Arc1p which
is associated in trans to S. cerevisiae methionyl-tRNA synthetase
(Fig. 2a). This association is mediated by the N-terminal domains
of Arc1p and methionyl-tRNA synthetase which display GST-like
folds [22]. Interestingly, human methionyl-tRNA synthetase also
possesses a C-terminally appended tRBD domain, but completely
unrelated to the OB-fold domain of the plant enzyme [23]. The
short C-terminal polypeptide extension of human methionyl-tRNA
synthetase displays a helix-turn-helix fold (Fig. 2c), rich in lysine
residues, also encountered appended to a variety of eukaryotic
aminoacyl-tRNA synthetases with different speciﬁcities [24,25].
After deletion of this domain, the afﬁnity for tRNAMet is strongly
decreased (Kd of 0.1 lM for the native enzyme and of 4 lM for
the deleted enzyme) [23].
Another well-studied example of tRBD appended to a human
synthetase is lysyl-tRNA synthetase [26–28]. Systematic site-direc-
ted mutagenesis of positively charged amino acid residues located
in the N-terminal appended tRBD of that enzyme, led to the iden-
tiﬁcation of a motif KxxxK(K/R)xxK which contributes the tRNA-
binding site [27]. The native enzyme has a potent tRNA-binding
capacity (Kd of 0.06 lM) and a deletion of the tRBD led to a 100-
fold decrease of the afﬁnity for tRNALys [27]. Human valyl-tRNA
synthetase, which displays a N-terminal tRBD containing the
tRNA-binding motif identiﬁed in human lysyl-tRNA synthetase,
also binds tRNA with high afﬁnity [29].) The smallest methionyl-tRNA synthetase, made of a catalytic (CAT) and anticodon-
N-terminal polypeptide extension contributes a protein-binding domain (PBD) that
e plant Oryza sativa (Os), a homologous tRBD is appended in cis at the C-terminus of
D that mediates association of this enzyme within the multi-synthetase complex
etase from A. aeolicus in complex with tRNAMet [18]. CAT is in green, ABD in orange.
involved in tRNA-binding [23] are indicated. (d) The crystal structure of EMAPII [21],
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Recognition and binding of tRNA to an aminoacyl-tRNA synthe-
tase of bacterial origin is generally mainly mediated by contacts
between the anticodon-binding domain of the synthetase and the
anticodon stem–loop domain of the tRNA molecule, and between
the catalytic domain of the enzyme and the acceptor stem of tRNA
[30]. What is the consequence of the presence of an additional
tRBD appended to the prokaryotic-like domain of a eukaryotic ami-
noacyl-tRNA synthetase? It improves tRNA-binding and, therefore,
could impair the rate of release of aminoacylated tRNA from the
synthetase. A 4-fold increase in KM for tRNA was observed in the
tRNA aminoacylation reaction after deletion of the tRBD of lysyl-
tRNA synthetase, consistent with the decreased afﬁnity observed
for tRNA, but a 2-fold increase in kcat was also reported [27]. Con-
cerning methionyl-tRNA synthetase, a 9-fold increase in KM for
tRNA and a 16-fold increase in kcat were reported in the tRNA
aminoacylation reaction catalyzed by the tRBD-truncated enzyme
[23]. Thus the turnover of the native enzyme is lower than that
of the truncated derivative, suggesting that the tRBD introduces a
limiting step in the tRNA aminoacylation reaction, with a slow re-
lease of the aminoacylated tRNA. In agreement with this predic-
tion, addition of EF1A in the aminoacylation reaction increased
the rate of Met-tRNAMet formation catalyzed by the native enzyme,
but had no effect on the activity of the truncated enzyme [23]. This
stimulation was dependent of the concentration of EF1A added,
showing that dissociation of aminoacyl-tRNA requires transient
association with EF1A. The ﬁnding that EF1A may also mediate
the release of Phe-tRNAPhe, or of Asp-tRNAAsp from their cognate
synthetase [31,32] suggests that the tRBDs contribute to the vecto-
rial transfer of tRNA from the synthetase to elongation factor 1A.
Aminoacyl-tRNAs would not be spontaneously released in the
cytosol after aminoacylation, in a distributive manner, but would
be transferred from hand to hand in a mechanism contributing
to the processivity of translation. The ﬁnding that two conforma-
tions of a tRNA–enzyme complex could be observed in a crystal
is consistent with this mechanism [33]. Co-crystals of human
tRNATrp-tryptophanyl-tRNA synthetase captured two types of
complexes: the association complex where tRNA is bound in a con-
formation suited for aminoacylation, and the dissociation complex
where tRNA is bound only by the anticodon. In the latter conforma-
tion, association of EF1A with the acceptor stem of tRNA can be
modeled without steric hindrance with the synthetase. This ter-
nary complex between a synthetase, a tRNA and elongation factor
EF1A could reﬂect a transient state that mediates the vectorial
transfer of tRNA from the synthetase to elongation factor 1A.
A paradigm of structural organization aimed to favor a mecha-
nism of direct transfer of aminoacyl-tRNA from the synthetase to
elongation factor EF1A was provided by the study of valyl-tRNA
synthetase in mammalian cells. This enzyme forms a complex with
elongation factor EF1A and with the three EF1B abc subunits that
constitute the GDP-exchange machinery of EF1A [34–38]. Interest-
ingly, a EF1AGTP-dependent stimulation of Val-tRNAVal formation
was observed with native valyl-tRNA synthetase, but not with a
tRBD-truncated enzyme [39]. This stable macromolecular assembly
is especially suited to ensure the direct transfer of the aminoacyl-
tRNA between enzymes catalyzing consecutive steps in translation.5. Processivity in translation
Processivity is commonly referred to as a mechanistic feature of
catalysis in which the substrate is not released from the active site
of an enzyme before many consecutive reactions are catalyzed. The
concept of processive enzyme has been primarily developed for en-zymes involved in the synthesis or in the degradation of polymers.
RNA, DNA, protein or sugar polymers are basic components of all
living organisms and many of the enzymatic machineries involved
in their biology are processive. This is a means to improve the efﬁ-
cacy of these cellular processes by getting rid of a diffusion-limit-
ing step. Processivity opposed to distributivity. Distributive
enzymes bind, modify and release their substrates without co-
ordination with other cellular processes.
Conceptually, processivity may also concern a mechanism by
which enzyme-N in a cellular process is coupled to reactions
N  1 and or N + 1 through the vectorial transfer of the reaction
product to the subsequent enzyme to avoid distribution of inter-
mediates throughout the cytoplasm. Such a ‘from hand to hand’
delivery of a reaction product to serve as a substrate requires that
product release from enzyme-N is a limiting step and is facilitated
by interaction with enzyme-(N + 1). If such were the case for all
reaction steps of a given synthetic pathway, a substrate might be
driven from enzyme-1 to enzyme-N without diffusion in the cellu-
lar environment, and in some cases back to enzyme-1.
The acquisition in evolution of potent tRBDs by eukaryotic ami-
noacyl-tRNA synthetases would be a means to ensure processivity
of tRNA handling in translation from the synthetase to elongation
factor EF1A (Fig. 3). At the stage of aminoacyl-tRNA delivery to the
ribosome, binding of the ternary complex EF1AGTPaatRNA is
reversible, the non-cognate ternary complex usually dissociates
from the ribosome without hydrolysis of GTP and release of
aatRNA, and thus replenishes the pool of ternary complex [40].
The mechanism by which deacetylated tRNA released from the
ribosome is directly captured by the synthetase to enter another
cycle without dissociation in the cytosol remains unclear. The ﬁnd-
ing that EF1A may form a ternary complex with uncharged tRNA
[41], or association of aminoacyl-tRNA synthetases with polyribo-
somes [42], could provide an answer.
Colocalization of components of the translation machinery has
been observed in dendrites of neurons [43]. Targeting of speciﬁc
mRNAs for translation to synapses or to cell periphery, and thus
of the translation machinery, was reported [44]. The extent of cor-
relation between mRNA distribution and subcellular localization
of the encoded proteins is believed to be a feature more general
than previously thought [45]. Association of aminoacyl-tRNA syn-
thetases and of elongation factor 1A with polyribosomes and with
actin cytoskeleton has been demonstrated and could be a means
to gather components of the translation machinery where transla-
tion takes place [46–48,42]. The subcellular assembly of transla-
tional compartment could contribute to the processivity of the
system.6. Structural determinants of processivity
Eukaryotic aminoacyl-tRNA synthetases contain different types
of tRBDs. The most frequent, found appended to methionyl, glut-
amyl-prolyl-, glycyl-, histidyl- or tryptophanyl-tRNA synthetase
is built around a helix-turn-helix domain [24,25]. Lysine residues
involved in tRNA-binding are located on one side of the domain
[23]. The appended domain of phenylalanyl-, tyrosyl-tRNA synthe-
tase and of p43, the accessory subunit of the MARS complex, folds
into an OB-fold conformation typical of other RNA binding proteins
[49,21]. The N-terminal extension of human lysyl-tRNA synthetase
is predicted to form an amphiphilic a-helix carrying the KxxxK(K/
R)xxK tRNA-binding motif on one side of the helix [27]. The solu-
tion structure of a tricosapeptide corresponding to the homologous
domain of yeast aspartyl-tRNA synthetase supports this hypothesis
[50]. The N-terminal appended domain of human aspartyl-, aspa-
raginyl-, valyl-, and possibly threonyl-tRNA sythetases may share
the tRNA binding mode of lysyl-tRNA synthetase.
Fig. 3. Processivity versus distributivity in a metabolic pathway. When a tRNA is aminoacylated by an aminoacyl-tRNA synthetase, the reaction product, the aminoacyl-tRNA
(aa  tRNA) is vectorially transferred to elongation factor EF1A, in a processive manner.
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an aminoacyl-tRNA synthetase comprises a catalytic domain and
a tRNA- (generally anticodon-) binding domain. It is noteworthy
that some bacterial synthetases do not only possess this minimal
set of structural domains. In E. coli, methionyl-tRNA synthetase
has a C-terminal EMAPII-like domain involved in dimerization
and tRNA binding [19]. The co-crystal structure of Pyrococcus hor-
ikoshii and Thermus thermophilus leucyl-tRNA synthetase [51,52],
of S. aureus isoleucyl-tRNA synthetase [53], and of T. thermophilus
valyl-tRNA synthetase [54], three enzymes with potent post-trans-
fer editing mechanisms, revealed that their C-terminal additional
domains contact other parts of the tRNA. The B2 domain of the
b-subunit of E. coli phenylalanyl-tRNA synthetase is an EMAPII-like
domain [55] that contributes to the editing activity of the enzyme
[56].
Several class I and class II aminoacyl-tRNA synthetases have
tRNA-dependent editing activities against mischarged, non-cog-
nate amino acids [57]. This proofreading mechanism requires that
misaminoacylated tRNAs are not spontaneously dissociated from
the synthetase after aminoacylation, but remain associated to the
enzyme before the CCA-end of tRNA reaches the editing site of
the enzyme where hydrolysis of mischarged tRNA occurs. This re-
quires that editing is kinetically favored as compared to aatRNA re-
lease. Because aminoacyl-tRNA synthetases with or without tRNA-
dependent editing activities generally possess or not additional do-
mains that interact with tRNA, the functional role of these ap-
pended domains could be to increase the residence time of
aminoacylated tRNA on the enzyme, thus favoring the proofread-
ing stage. One may speculate that tRBDs appended to eukaryotic
aminoacyl-tRNA synthetases to ensure processivity in translation
are functionally and evolutionary related to tRBDs involved in
tRNA-dependent post-transfer editing.7. Concluding remarks
Processivity of ribosomes, of DNA or RNA polymerases, of endo-
or exonucleases, DNA glycosylases, or cellulases is achieved by to-
tal or partial enclosure of the substrate within a deep groove in the
enzyme [58]. Sometimes, a host protein is hijacked to enclose the
substrate, as in the case of T7 DNA polymerase that uses thiore-
doxin as a processivity factor. Concerning eukaryotic aminoacyl-
tRNA synthetases, sequestration of tRNA in the translation process
is also achieved by tRBDs appended in cis or in trans of the catalytic
domains of the synthetases. Conversely, it is amazing that an ami-
noacyl-tRNA synthetase, or a protein related to this family of en-
zymes, has been enrolled to serve as a processivity factor for
human mitochondrial DNA polymerase [59].This review summarized data supporting the hypothesis
according to which translation in the eukaryote cell is a processive
mechanism, where tRNA is strictly chaperoned by the components
of the translation apparatus. Emerging evidence indicates that
components of the translation apparatus have moonlighting func-
tions that have to be strictly regulated [60]. This suggests that the
spatio-temporal organization of translation is a key element of cel-
lular homeostasis. In prokaryotes, where subcellular organization
is much less developed, increasing concentrations of the different
components of translation apparatus could palliate free diffusion.
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